The recent “super office” reorganization in the US Food and Drug Administration’s Center for Devices and Radiological Health has contributed to a drop in the number of warning letters issued over the past two years, according to an FDA official.
Erin Keith, CDRH’s associate director for compliance and quality, spoke as part of an FDA compliance panel at the Food and Drug Law Institute’s Enforcement, Litigation and Compliance conference in...